1. Home
  2. CTGO vs PROK Comparison

CTGO vs PROK Comparison

Compare CTGO & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contango ORE Inc.

CTGO

Contango ORE Inc.

N/A

Current Price

$22.73

Market Cap

382.6M

ML Signal

N/A

Logo ProKidney Corp.

PROK

ProKidney Corp.

N/A

Current Price

$2.16

Market Cap

331.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTGO
PROK
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.6M
331.2M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
CTGO
PROK
Price
$22.73
$2.16
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.40
AVG Volume (30 Days)
224.0K
509.6K
Earning Date
06-19-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
19.77
N/A
EPS
N/A
N/A
Revenue
N/A
$76,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.22
$0.46
52 Week High
$34.38
$7.13

Technical Indicators

Market Signals
Indicator
CTGO
PROK
Relative Strength Index (RSI) 34.60 44.70
Support Level $20.92 $2.09
Resistance Level $24.32 $2.58
Average True Range (ATR) 1.39 0.16
MACD -0.55 -0.02
Stochastic Oscillator 7.51 0.00

Price Performance

Historical Comparison
CTGO
PROK

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: